FYR Diagnostics, Texas A&M University, and University of New Mexico awarded NIH grant for early detection of Neonatal Opioid Withdrawal Syndrome (NOWS)

MISSOULA, MONTANA, August 31, 2022 – Newborns develop Neonatal Opioid Withdrawal Syndrome (NOWS) when the mother is exposed to opioids and passes exposure to their unborn child. NOWS cases surged from 1.5 per 1,000 hospital births in 2004 to 8 per 1,000 in 2014. Symptoms of NOWS in newborns range from mild and temporary to …

FYR Diagnostics, Texas A&M University, and University of New Mexico awarded NIH grant for early detection of Neonatal Opioid Withdrawal Syndrome (NOWS) Read More »